Attention As daylight saving time has already ended in Europe, while the United States will not switch until November 1, trading hours are temporarily shifted. As a result, Knock-Out products linked to U.S. underlyings may be knocked out between 2:30 p.m. and 9:00 p.m. (CET) during this period. Following the U.S. time change, the usual Knock-Out hours of 3:30 p.m. to 10:00 p.m. (CET) will apply again.
Product was called ・
Repayment date: 30/06/2026 AstraZeneca Group PLC, BioNTech SE, Novartis AG Coupon p.a.: 7.00%Issuercallable CHF Maturity: 19/03/2027
ISIN CH1449121818 Valor 144912181 Symbol RMAZVV
Key figures View More Bonus amount per interval
1.75% (17.50 CHF)
Call interval (in months)
3
Next Call Date
–
Next Coupon Payment
–
Next Coupon Ex-Date
28/12/2026
AstraZeneca Group PLC Strike
113.04 GBP
Barrier
62.17 GBP (55.00%)
Distance to Barrier
–
Ratio
8.84643
BioNTech SE Strike
96.22 USD
Barrier
52.92 USD (55.00%)
Distance to Barrier
–
Ratio
10.39285
Novartis AG Strike
97.77 CHF
Barrier
53.77 CHF (55.00%)
Distance to Barrier
–
Ratio
10.22809
Life Cycle 19/09/2025 Initial Fixing 25/09/2025 First trading day 23/06/2026 Called 30/06/2026 Redemption About this product Like the classic version, Multi Callable Barrier Reverse Convertibles (BRCs) are characterized by a pre-determined coupon and a safety buffer up to the barriers. The callable attribute improves the yield because coupons are generally higher than for regular Multi BRCs, but investors bear the reinvestment risk if the products are redeemed ("called") early.